Dr. Humeira Badsha Publications

Articles - Peer Reviewed:

1. Badsha H, Gunes B, Grossman J, Brahn E. Troponin I assessment of cardiac involvement in patients with connective tissue disease and an elevated creatine kinase MB isoform. J. Clin Rheum. 3 : 131-134, 1997.

2. Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R, Wallace DJ, Kitridou RC, Chen SL, Shen N, Song YW, Isenberg DA, Yu CL, Hahn BH, Rotter Jl. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997 Feb 15; 99 (4) : 725-31.

3. Melioidosis in systemic lupus erythematosus: the importance of early diagnosis and treatment in patients from endemic areas. H Badsha, CJ Edwards, HH Chng. Lupus. 2001;10(11):821-23

4. Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications. Badsha H; Kong KO; Lian TY; Chan SP; Edwards CJ; Chng HH Lupus, 15 August 2002, vol. 11, no. 8, pp. 508-513(6)

5. Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil Cheng Lay Teh, Kok Ooi Kong, Angela Chong, Humeira Badsha Lupus. 2002;11(4):249-52.

6. Intravenous pulses of methylprednisolone for SLE. Badsha H,Edwards CJ. Seminars in Arthritis and Rheumatism vol 32, no 5 april 2003 pp

7. Intermittent epoprostenol infusion in systemic lupus erythematosus associated pulmonary hypertension – a series of 3 cases. Kok Ooi Kong, Humeira Badsha, Julian Thumboo, Hiok Hee Chng. Annals Academy of Medicine Singapore January 2003,vol 32 no. 1 pp 118-21

8. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome Edwards CJ, Lian TY, Badsha H, Te CL, Arden N, Chng HH.
Lupus . 2003; 12(9):672-6.

9. Usefulness of serum soluble CD38 and CD 157 levels in differentiating SLE, RA and healthy adults and their relationship with disease activity. Kong KO, Leung BP, Chng HH, Thong BY, Koh ET, Leong KP, Badsha H, Lian Ty, Khoo KM, Howe HS. Ann Acad of Med Singapore 2003 sep; 32 (5 suppl) S16-7

10. Low-dose pulse methylprednisolone is an effective therapy for severe SLE flares.Lupus. 2004;13(3):212-3 Kong KO, Badsha H, Lian TY, Edwards, CJ, Chng HH

11. Pulmonary Haemorrhage in Systemic Lupus Erythematosus H Badsha, CL The, KO Kong, TY Lian, HH Chng. Seminars in Arthritis and Rheumatism 33/6 pp. 414-421

12. Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis. Rheumatology (Oxford). 2005 Jan;44(1):51-4 Howe HS, Cheung PL, Kong KO, Badsha H, Thong BY, Leong KP, Koh ET, Lian TY, Cheng YK, Lam S, Teo D, Lau TC, Leung BP

13. Psychometric properties of a new systemic lupus erythematosus-specific quality-of- life instrument (SLEQOL). Ann Acad Med Singapore. 2004 Sep;33(5 Suppl):S35Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, The CL, Cheng YK, Chng HH, Badsha H, Law WG, Lau TC, Chew LC, Ho HJ, Pong LY, Hoi LS, Nagarajan S, Chan SP, Howe HS.

14. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford). 2005 Mar 29 Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, Cheng YK, Chng HH, Badsha H, Law WG, Lau TC, Chew LC, Ho HJ, Pong LY, Hoi LS, Sangeetha N, Chan SP, Howe HS

15. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 Jul 25;54(8):2541-2549. Mc Mohan M, Grossman J, Fitzgerald J, Dahlin Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH

16. Association of a common complement receptor 2 haplotype with increased risk of SLE. Proc. Natl. Acad. Sci. In press. Wu H, Boackle SA, Hanvivadhanaku P, Ulgiati D, Grossman JM, Lee Y, Shen N, Abraham LJ, Mercer TR, Park E, Hebert LA, Rovin BH, Birmingham DJ, Chang D, Chen CJ, McCurdy D, Badsha HM, Thong BYH, Chng HH, Arnett FC, Wallace DJ, Yu CY, Hahn BH, Cantor RM, Tsao BP.

17. Rheumatoid arthritis in Dubai--delayed diagnosis and low usage of disease modifying antirheumatic drugs Ann Rheum Dis. 2007 Jun;66(6):835 Badsha H, Kong KO, Tak PP

Book Chapters:

Badsha H, Rheumatoid Arthritis. A Clinical Approach to Medicine. 1st edition. Ong YY, Woo KT,

ABSTRACTS:

1. European league against rheumatology annual meetings. [ab0253] predictive model of mortality among patients admitted to a tertiary centre

Authors: T.Y. Lian 1, K.O. Kong 1, H. Badsha 1, C.L. Teh 1, H.H. Chng 1
Year: 2003

2. [Thu0150] Characteristics Of Patients Presenting With Inflammatory Arthritis To A Musculoskeletal Disease Clinic In Dubai

Authors: H. Badsha, P.P. Tak
Year: 2006

3. [Thu0151] Characteristics Of 357 Admissions Of Systemic Lupus Erythematosus Patients To A Rheumatology Department During One Year

Authors: C.J. Edwards 1, T.Y. Lian 2, H. Badsha 2, H.H. Chng 2
Year: 2002

4. [Thu0141] Risk Factors For Serious Infections In Lupus Nephritis Patients Treated With High Dose Prednisolone

Authors: K.O. Kong, T.Y. Lian, H. Badsha, H.H. Chng
Year: 2002

5. [Thu0043] Usefulness Of Serum Soluble Cd38 And Cd157 Levels In SLE And Ra - Relationship With Disease Activity

Authors: K. Kong 1, B. Leung 1, H. Chng 1, B. Thong 1, E. Koh 1, K. Leong 1, H. Badsha 1, T. Lian 1 , K. Khoo 1, H. Howe 1
Year: 2003

6. [Ab0281] Low Dose Pulse Methylprednisolone Is Effective Therapy For SLE Flares: A Prospective Study

Authors: T.Y. Lian 1, H. Badsha 1, K.O. Kong 1, C.J. Edwards 2, H.H. Chng 1
Year: 2003

7. [Ab0264] Changing Patterns Of Lupus Mortality In A Tertiary Centre In Singapore

Authors: W.G. Law 1, C.L. Teh 1, H. Badsha 1, T.Y. Lian 1, K.O. Kong 1, E.T. Koh 1, H.H. Chng 1
Year: 2003

8. [Thu0280] interferon-inducible protein 10 (ip-10) is a potential biomarker of disease activity in SLE

Authors: k.o. kong1, b.y.h. thong 1 , t.y. lian 1 , h.h. chng 1 , y.k. cheng 1 , c.l. teh 1 , e.t. koh 1 , w.g . Law 1 , w.h. yong 1 , l.c. chew 1 , t.c. lau 1 , h. Badsha 1 , k.p. leong 1 , b.p.l. leung 2 , h.s. howe 1
Year: 2006

AMERICAN COLLEGE OF RHEUMATOLOGY ANNUAL SCIENTIFIC MEETINGS

1997

A susceptibility gene for SLE maps to a 5 cM region of human chromosome 1q.

BP Tsao, RM Cantor, H Badsha, JM Grossman, KC Kalunian, H Hartung, FC Arnett, DJ Wallace, BH Hahn, JI Rotter.

Arthritis and Rheumatism, volume 40, No.9 (supplement)

2000
Pulmonary hypertension in systemic lupus erythematosus Treatment with Intermittent epoprostenol infusion

Kong KO, Badsha H, Thumboo J, Pao Hsii Feng

Arthritis and Rheumatism vol 43 No.9 (supplement)

2001
Pulse Methylprednisolone for SLE flares: A lower dose decreases the risk of serious infections without reducing efficacy

Badsha H; Kong KO; Lian TY; Chan SP; Edwards CJ; Chng HH

Arthritis and Rheumatism vol 44 No.9 (supplement) p. S280

2002Risk Factors for Serious Infections among Lupus Nephritis Patients Treated with High Dose Prednisolone
Category: 23 SLE—clinical aspects

Tsui Yee Lian, Kok Ooi Kong, Humeira Badsha, Hiok Hee Chng

Arthritis and Rheumatism vol 45 No.9 (supplement)

SLEDAI and SLAM are Useful Indicators of Disease Activity in Lupus Patients with Pulmonary Haemorrhage
Category: 23 SLE—clinical aspects
Humeira Badsha, Cheng Lay Teh, Kok Ooi Kong, Tsui Yee Lian, Hiok Hee Chng
Arthritis and Rheumatism vol 45 No.9 (supplement) p

2003
Markers In A 1-Mb Interval Within 1q23.3 Are Associated With Systemic Lupus Erythematosus Susceptibility
Hui Wu, Rita M. Cantor, Jennifer M. Grossman, Alexis A. Rumbin, Nan Shen , Chak S. Lau, Daniel J. Wallace, Frank C. Arnett, Humeira M. Badsha, Hiok H. Chng, Bevra H. Hahn, Betty P. Tsao

Arthritis and Rheumatism vol 46 No.9 (supplement) p

TGF Beta Polymorphisms and Serum TGF Levels in Oriental Patients with Ankylosing Spondylitis
Category: 27 Spondylarthropathies
Hwee Siew Howe , Po Loong Cheung, Kok Ooi Kong, Humeira Badsha, Bernard Thong, Khai Pang Leong, Tang Ching Lau, Ee Tzun Koh, Tsui Yee Lian , Yew Kuang Cheng, Diana Teo, Sally Lam, Bernard P. Leung.

Arthritis and Rheumatism vol 46 No.9 (supplement) p

2004
SLAM and SLEDAI are Valid Disease Activity Measures in Oriental Lupus Patients with SLEDAI being More Sensitive to Change
Kok Ooi Kong, Bernard YuHor Thong, Tsui Yee Lian, Cheng Lay Teh, Ee Tzun Koh, Yew Kuang Cheng, Hiok Hee Chng, Weng Giap Law, Tang Ching Lau, Humeira Badsha, Khai Pang Leong, Li Ching Chew, Hwee Siew Howe.

Arthritis and Rheumatism vol 47 No.9 (supplement) p

What Does Patient Global Assessment of Health Measure when SLE Patients are Asked to Evaluate their Own General Health?
Kok Ooi Kong, Bernard Yu Hor Thong, Tsui Yee Lian, Cheng Lay Teh, Ee Tzun Koh, Yew Kuang Cheng, Hiok Hee Chng, Weng Giap Law, Tang Ching Lau, Humeira Badsha, Khai Pang Leong, Li Ching Chew, Hwee Siew Howe.

Arthritis and Rheumatism vol 47 No.9 (supplement) p

Atherosclerosis in SLE May Relate to Abnormal Protective Capacity of HDL
Maureen A. McMahon1, Jennifer Grossman, John Fitzgerald, Fanny Ebling, Erika Dahlin-Lee, Bernard Thong, Kenneth Kalunian, Daniel J. Wallace, Humeira Badsha , Mohamad Navab, Alan M. Fogelman, Bevra H. Hahn. Hiok Hee Chng

Arthritis and Rheumatism vol 47 No.9 (supplement) p



Evidence for SLE Susceptibility Gene(s) at 1q32
Young Ho Lee, Hui Wu, Rita M. Cantor, Jennifer M. Grossman, Alexis A. Rumbin, Elly Park1, Nan Shen, Chung Jen Chen , Humeira M. Badsha, Bernard YH Thong, Hiok H. Chong, Daniel J. Wallace, Bevra H. Hahn, Betty P. Tsao

Arthritis and Rheumatism vol 47 No.9 (supplement) p.

2005
Interferon-Inducible protein 10 (IP-10) in SLE: A Potential Biomarker with Good Correlation with Disease Activity.

Kok Ooi Kong, Bernard Yu Hor Thong, Tsui Yee Lian, Hiok Hee Chng, Yew Kuang Cheng, Cheng Lay Teh, Ee Tzun Koh , Weng Giap Law, Wern Hui Yong, Li Ching Chew, Tang Ching Lau, Humeira Badsha, Khai Pang Leong, Bernard Pui Lam Leung, Hwee Siew Howe

Pro-Inflammatory HDL as a Biomarker for Atherosclerosis in SLE and RA

Author(s):
Maureen McMahon, Jennifer Grossman, John Fitzgerald, Erika Dahlin-Lee, Fanny Ebling, Bernard Thong, Humira Badsha , Daniel J. Wallace, Kenneth Kalunian, Bevra Hahn.

Arthritis and Rheumatism vol 48 No.9 (supplement) p

2006
Association of a Common Haplotype of Complement Receptor 2 (CR2) with Increased Risk of SLE

H. Wu, S. Boackle, P. Hanvivadhanakul, D. Ulgiati, J. Grossman, Y. Lee, N. Shen, L. Abraham, T. Mercer , E. Park, L. Hebert, B. Rovin, D. Birmingham, D. Chang, C. Chen, D. McCurdy, H. Badsha, B. Thong, H. Chng, F. Arnett, D. Wallace, C. Y Yu, B. Hahn, R. Cantor, B. Tsao.

Arthritis and Rheumatism vol 49 No.9 (supplement) p